#medicalcannabis #cbd #cannabiscommunity #cannabidioll #alternativeinvestments #diversification #privatemarkets #privatedebt #therapeutic | Rainer L.
#medicalcannabis #cbd #cannabiscommunity #cannabidioll #alternativeinvestments #diversification #privatemarkets #privatedebt #therapeutic According to a report by analytics and market research firm Brightfield Group, which provides benchmark data for legal CBD and cannabis industries, Europe’s cannabis and cannabidiol (CBD) markets are set to grow exponentially over the next few years, with the cannabis sector set to rise over 2400 % and CBD set to grow over 400 % by 2023. Europe’s CBD market was estimated at $318m in 2018 and is tipped to rise to $416m in 2019, according to the report. CBD is then expected to grow to nearly $1.7bn by 2023. Cannabis consists of the dried flowers of the female hemp plant (Cannabis sativa L) and is often called marijuana or weed. Cannabis contains a number of different active ingredients. Tetrahydrocannabinol (THC) is usually the main active ingredient, but other components - such as cannabidiol (CBD) - also have an effect. The particular composition determines the effects and side effects of the cannabis. Cannabis dispensed by a pharmacy has to meet stringent quality requirements. This cannabis is intended for therapeutic purposes, which is why it is called medical cannabis. https://lnkd.in/dhZHudMwww.linkedin.com
